Abstract
Interleukin-1β (IL-1β) is a multifunctional proinflammatory cytokine upregulated in acute phase of heart ischemic disease. Controversial effects of IL-1β have been demonstrated on endothelial progenitor cells (EPCs) functional activity. The aim of this study was to investigate the in vitro effect of IL-1β on activity of human origin EPCs and the possible mechanism involved. EPCs were isolated from peripheral blood of healthy volunteers without cardiovascular risk factors and characterized. After ex vivo cultivation, EPCs were stimulated with a series of final concentrations (0, 0.1, 1, and 10 ng/ml) of IL-1β for 24 h. In some other experiments, EPCs were pretreated with 10 μM LY294002 (Akt inhibitor) for 30 min and then stimulated with 1 ng/ml IL-1β for 24 h. Cell proliferation, apoptosis, adhesion, and migration were determined, respectively, by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, annexin V/propidium iodide binding assay, adhesion assay, and transwell migration assay. In addition, the vascular endothelial vascular growth factor-A (VEGF-A) production has been examined using quantitative real-time RT-PCR and ELISA assay. Furthermore, the total and phosphorylation level of Akt was determined by Western blot. IL-1β significantly stimulated EPC proliferation, migration, and adhesion and upregulated the angiogenic growth factor VEGF-A at mRNA and protein level, while exerted no influence on cell apoptosis. However, pretreatment with LY294002 significantly diminished IL-1β-induced proliferation, migration, adhesion, and VEGF-A production. One nanogram per milliliter IL-1β for 15 min activated phosphorylation of Akt. These results suggest a potent role for IL-1β in upregulating EPCs functions. The phosphatidyl-inositol-3-kinase-Akt signaling pathway could be involved in the regulation of EPCs functions induced by IL-1β.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10753-012-9434-9/MediaObjects/10753_2012_9434_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10753-012-9434-9/MediaObjects/10753_2012_9434_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10753-012-9434-9/MediaObjects/10753_2012_9434_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10753-012-9434-9/MediaObjects/10753_2012_9434_Fig4_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10753-012-9434-9/MediaObjects/10753_2012_9434_Fig5_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10753-012-9434-9/MediaObjects/10753_2012_9434_Fig6_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10753-012-9434-9/MediaObjects/10753_2012_9434_Fig7_HTML.gif)
Similar content being viewed by others
Abbreviations
- EPCs:
-
Endothelial progenitor cells.
- HIF-1α:
-
Hypoxia-inducible factor 1α.
- IL-1β:
-
Interleukin-1 beta.
- M199:
-
Medium 199.
- MNCs:
-
Mononuclear cells.
- MTT:
-
3-(4 5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide.
- PBS:
-
Phosphate-buffered saline.
- VEGF:
-
Endothelial vascular growth factor.
- VEGF-A:
-
Endothelial vascular growth factor-A.
- PI3K:
-
Phosphatidylinositol 3-kinase
References
Asahara, T., T. Murohara, A. Sullivan, M. Silver, R. van der Zee, T. Li, et al. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964–967.
Hristov, M., W. Erl, and P.C. Weber. 2003. Endothelial progenitor cells: Mobilization, differentiation, and homing. Arteriosclerosis, Thrombosis, and Vascular Biology 23: 1185–1189.
Amano, K., M. Okigaki, Y. Adachi, S. Fujiyama, Y. Mori, A. Kosaki, et al. 2004. Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice. Journal of Molecular and Cellular Cardiology 36(4): 469–480.
Werner, N., and G. Nickenig. 2006. Influence of cardiovascular risk factors on endothelial progenitor cells: Limitations for therapy? Arteriosclerosis, Thrombosis, and Vascular Biology 26: 257–266.
Urbich, C., A. Aicher, C. Heeschen, E. Dernbach, W.K. Hofmann, A.M. Zeiher, et al. 2005. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. Journal of Molecular and Cellular Cardiology 39: 733–742.
Yamazaki, Y., and T. Morita. 2006. Molecular and functional diversity of vascular endothelial growth factors. Molecular Diversity 10: 515–527.
Jia, H., A. Bagherzadeh, R. Bicknell, M.R. Duchen, D. Liu, and I. Zachary. 2004. Vascular endothelial growth factor (VEGF)-D and VEGF-A differentially regulate KDR-mediated signaling and biological function in vascular endothelial cells. Journal of Biological Chemistry 279: 36148–36157.
Dimmeler, S., A. Aicher, M. Vasa, C. Mildner-Rihm, K. Adler, M. Tiemann, et al. 2001. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. The Journal of Clinical Investigation 108: 391–397.
Qiu, F.Y., X.X. Song, H. Zheng, Y.B. Zhao, and G.S. Fu. 2009. Thymosin beta4 induces endothelial progenitor cell migration via PI3K/Akt/eNOS signal transduction pathway. Journal of Cardiovascular Pharmacology 53(3): 209–214.
Wada, T., and J.M. Penninger. 2004. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23: 2838–2849.
Ono, K., A. Matsumori, T. Shioi, Y. Furukawa, and S. Sasayama. 1998. Cytokine gene expression after myocardial infarction in rat hearts: Possible implication in left ventricular remodeling. Circulation 98: 149–156.
Pudil, R., V. Pidrman, J. Krejsek, J. Gregor, M. Tichý, C. Andrýs, et al. 1999. Cytokines and adhesion molecules in the course of acute myocardial infarction. Clinica Chimica Acta 280(1–2): 127–134.
Henrich, D., C. Seebach, K. Wilhelm, and I. Marzi. 2007. High dosage of simvastatin reduces TNF-alpha-induced apoptosis of endothelial progenitor cells but fails to prevent apoptosis induced by IL-1beta in vitro. Journal of Surgical Research 142: 13–19.
Rosell, A., K. Arai, J. Lok, T. He, S. Guo, M. Navarro, et al. 2009. Interleukin-1beta augments angiogenic responses of murine endothelial progenitor cells in vitro. Journal of Cerebral Blood Flow and Metabolism 29: 933–943.
Chen, J.Z., J.H. Zhu, X.X. Wang, J.H. Zhu, X.D. **e, J. Sun, et al. 2004. Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood. Journal of Molecular and Cellular Cardiology 36: 233–239.
Wang, X.X., F.R. Zhang, Y.P. Shang, J.H. Zhu, X.D. **e, Q.M. Tao, et al. 2007. Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: A pilot randomized controlled trial. Journal of the American College of Cardiology 49(14): 1566–1571.
Hu, X.S., C.Q. Du, L. Yang, X.Y. Yao, and S.J. Hu. 2010. Proteasome inhibitor MG132 suppresses number and function of endothelial progenitor cells: Involvement of nitric oxide synthase inhibition. International Journal of Molecular Medicine 25(3): 385–392.
**a, L., X.X. Wang, X.S. Hu, X.G. Guo, Y.P. Shang, H.J. Chen, et al. 2008. Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms. British Journal of Pharmacology 155: 387–394.
Yang, Z., J.M. Wang, L. Chen, C.F. Luo, A.L. Tang, and J. Tao. 2007. Acute exercise-induced nitric oxide production contributes to upregulation of circulating endothelial progenitor cells in healthy subjects. Journal of Human Hypertension 21: 452–460.
Qin, S.L., T.S. Li, M. Takahashi, and K. Hamano. 2006. In vitro assessment of the effect of interleukin-1beta on angiogenic potential of bone marrow cells. Circulation Journal 70: 1195–1199.
Fan, F., O. Stoeltzing, W. Liu, M.F. McCarty, Y.D. Jung, N. Reinmuth, et al. 2004. Interleukin-1beta regulates angiopoietin-1 expression in human endothelial cells. Cancer Research 64: 3186–3190.
Asahara, T., T. Takahashi, H. Masuda, C. Kalka, D. Chen, H. Iwaguro, et al. 1999. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO Journal 18: 3964–3972.
Fadini, G.P., I. Baesso, M. Albiero, S. Sartore, C. Agostini, and A. Avogaro. 2008. Technical notes on endothelial progenitor cells: Ways to escape from the knowledge plateau. Atherosclerosis 197: 496–503.
Richardson, M.R., and M.C. Yoder. 2011. Endothelial progenitor cells: Quo Vadis? Journal of Molecular and Cellular Cardiology 50(2): 266–272.
Acknowledgments
We thank Jun- Hui Zhu and Mohamed S. Draz for the critically reviewing the manuscript.
Conflicts of Interest
The authors have no conflicting financial interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yang, L., Guo, XG., Du, CQ. et al. Interleukin-1 Beta Increases Activity of Human Endothelial Progenitor Cells: Involvement of PI3K-Akt Signaling Pathway. Inflammation 35, 1242–1250 (2012). https://doi.org/10.1007/s10753-012-9434-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-012-9434-9